Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
Publication Date On Demand
Product Type Report
Single User License help $ 2000.00
Site User License help $ 4000.00
Corporate User License help $ 6000.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

DelveInsight’s, “ Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
• A snapshot of the global Market therapeutics scenario for Absence Seizure.
• A review of the marketed products under prescription for Absence Seizure, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Absence Seizure with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Absence Seizure drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Absence Seizure drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Absence Seizure drugs.
• Coverage of Absence Seizure Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2011-2015.

Reasons to Buy
• Evaluate the marketing status and exclusivity details of Absence Seizure key products to exploit opportunities for generic drug development opportunities.
• Identify and understand important and diverse types of therapeutics under Phase III development for Absence Seizure.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to ‘Disease’.
• API intelligence over marketed drugs for Absence Seizure and gaining primary intelligence over active ingredients manufacturers across the globe.
• API intelligence over leading Phase III pipeline drugs.
• Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
• Understanding the scope of the Phase III Drugs with nil regulatory filings.
• Understanding the chemical route of synthesis of approved drugs for Absence Seizure.
• Uncovering opportunities in the rapidly growing the US markets.


Companies Mentioned

Novartis AG Shire Laboratories, Inc. Abbott Laboratories Pfizer Inc. Noven Pharmaceuticals, Inc. AbbVie Inc.

• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Forecasted Sales Figures (2011-2015)
• Marketed Drugs Information
• Drugs Description
• Route of Synthesis
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Phase III Drugs Information
• Phase III Drugs Description
• The United States Drug Master Filings (US DMF)
• Discontinued Drugs Information

List of Tables
Absence Seizure Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Absence Seizure Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Absence Seizure Therapeutic Market, US, (Year), 2014
Absence Seizure Marketed Drugs, API Manufacturers by US DMF Status, 2014
Absence Seizure Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Absence Seizure Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Absence Seizure Therapeutic Market, Global Sales (in million USD), 2014
Absence Seizure Marketed Drugs, API Manufacturers, Global, 2014
Absence Seizure Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Absence Seizure, 2014

List of Figures
Absence Seizure Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Absence Seizure Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Absence Seizure Therapeutic Market, US, (Year), 2014
Absence Seizure Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Absence Seizure Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Absence Seizure Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Absence Seizure Therapeutic Market, Global Sales (in million USD), 2014
Absence Seizure Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

Title Date Price
2013 Deep Research Report on China Human Use Rabies Vaccine Industry
By QYResearch
2013 Deep Research Report on China Human Use Rabie Vaccine Industry is a professional and depth research report on China Human Use Rabies Vaccine industry. This report has firstly introduced Human Use ...Read More
Jan 2013 $2000.00
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
Abdominal Obesity-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Abdominal Obesity-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establ ...Read More
$1250.00
Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...Read More
$2000.00
Abortion-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00
Abscess- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Abscess- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...Read More
$2000.00
Abscess-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00
Abscess-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Abscess-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the un ...Read More
$1250.00
Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and m ...Read More
$2000.00
Absence Seizure-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  Delveinsight

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z